Today: 7 February 2026
Subscribe

Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

Chilean lithium giant jumps ~12% on Monday as big funds buy in, lithium prices spike on China optimism, and investors brace for Q3 2025 earnings. Sociedad Química y Minera de Chile S.A. (NYSE: SQM) is back in the spotlight. By late morning on Monday, SQM’s New York–listed shares were up roughly 11–12% around $61, hitting fresh 52‑week highs and extending a sharp rally that began after China cleared its landmark lithium joint venture with state miner Codelco.MarketBeat+1 Today’s surge comes as: Here’s what’s driving SQM today – and what to watch next. 1. Big funds are quietly loading up on
17 November 2025
··
PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (NYSE: PACS) jumps more than 40–50% after announcing plans to file all overdue SEC reports and release Q3 2025 earnings on November 19, easing delisting and default fears for the nursing-home giant. Shares of PACS Group, Inc. (NYSE: PACS) exploded higher on Monday after the post‑acute care operator said it will finally clear a months‑long SEC reporting backlog this week, a move seen as critical to keeping its New York Stock Exchange listing and stabilizing its financing. By late morning, PACS stock was trading around $15.90, up roughly 50% on the day and rebounding from a bruising slide
17 November 2025
ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) is back in the spotlight today, November 17, 2025, as the stock trades sharply higher while fresh institutional buying, surging options activity and a looming earnings release collide in a single, high‑volatility narrative. As of late morning U.S. trading, ZIM shares are changing hands around $17.0, up roughly 6–6.5% on the day, with an intraday range near $16.54–$17.50 and a 52‑week band of about $11–$29. Investing.com+1 At the same time, a new filing shows Bulltick Wealth Management LLC has significantly increased its position, options markets are pricing an ≈12% move around Thursday’s earnings
17 November 2025
·
Lucid Group (LCID) Stock Crashes to New All‑Time Low as Stifel Slashes Target and $875M Debt Deal Closes

Lucid Group (LCID) Stock Crashes to New All‑Time Low as Stifel Slashes Target and $875M Debt Deal Closes

Lucid Group, Inc. (NASDAQ: LCID) is under intense pressure today as its share price sinks to a new all‑time low, capping a brutal two‑week slide driven by weak earnings, fresh debt, analyst downgrades and ongoing concerns about cash burn at the Saudi‑backed EV maker. By late morning on Monday, Lucid stock was trading around $13.31, down more than 6% on the day and extending a steep decline of over 35% since mid‑October, according to real‑time data from Investing.com.Investing.com The move pushes LCID to fresh 52‑week lows and, according to several market outlets, to the lowest level since the company went
17 November 2025
··
Ashurst–Perkins Coie Merger Creates $2.7 Billion Transatlantic Megafirm in Big Law Shake-Up

Ashurst–Perkins Coie Merger Creates $2.7 Billion Transatlantic Megafirm in Big Law Shake-Up

LONDON / SEATTLE — November 17, 2025 — London-headquartered Ashurst and US firm Perkins Coie have agreed to merge in a landmark transatlantic deal that will create a top‑20 global law firm with around 3,000 lawyers and annual revenue of about $2.7 billion. Operating under the new brand Ashurst Perkins Coie, the combined outfit will span 52 offices in 23 countries, cementing its status as one of the largest law firms in the world. Reuters+2Legal Cheek+2 A New Top‑20 Global Law Firm The merger is formally being described as a “combination of equals”, uniting two long‑established firms with more than
17 November 2025
Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer Inc. (NYSE: PFE) is back in the headlines today with a flurry of developments that span new product launches, obesity-drug M&A, fresh vaccine data and ongoing debate about whether its battered stock is finally a buy. As of this afternoon, Pfizer shares are trading around $25.28, little changed on the day, and still down roughly 55% from their late‑2022 peak, leaving the dividend yield near the 7% level that has attracted income‑focused investors.sharewise.com+1 Below is a breakdown of the key Pfizer news and stock drivers for November 17, 2025. Market snapshot: PFE on November 17, 2025 Short‑term quantitative models
17 November 2025
··
GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

On Monday, November 17, 2025, GameStop (NYSE: GME) is back at the center of the market conversation as its share price hovers just above $20 while retail traders debate new lows, short‑squeeze odds, and the company’s latest viral promotion, “Trade Anything Day.” At the same time, analysts are re‑running their models on GameStop’s valuation after a profitable streak, Bitcoin‑linked treasury moves and a massive convertible note sale earlier this year. markets.businessinsider.com+2Simply Wall St+2 GME stock today: modest bounce after fresh 52‑week low In late‑morning trading on Monday, GameStop shares were changing hands around $20.7–$20.8, up a few tenths of a
17 November 2025
Social Security COLA 2026 and the $200 Boost Bill: How Much Your Check Could Really Rise (Update for November 17, 2025)

Social Security COLA 2026 and the $200 Boost Bill: How Much Your Check Could Really Rise (Update for November 17, 2025)

Let’s break down what’s locked in, what’s still just a proposal, and what it all means for your 2026 Social Security income as of today, November 17, 2025. 1. The 2026 COLA is official: 2.8% across Social Security and SSI On October 24, the Social Security Administration (SSA) confirmed that benefits will rise 2.8% in 2026, based on inflation as measured by the CPI‑W (Consumer Price Index for Urban Wage Earners and Clerical Workers). SSA According to SSA’s 2026 COLA fact sheet: Social Security The COLA is permanent. Once your benefit is adjusted upward, that higher base stays in place
17 November 2025
Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Automotive, Inc. (NASDAQ: RIVN) is having another eventful Monday. After a huge post‑earnings rally, the electric‑vehicle maker is now caught between bullish Wall Street upgrades, negative headlines about a battery‑calibration problem, and fresh disclosures showing big investors trimming their stakes. As of early afternoon on November 17, Rivian stock is trading around $15.06, down slightly on the day after last week’s surge. The stock remains up strongly over the past month thanks to a surprise move into positive gross profit in Q3 2025 and a series of upbeat analyst notes.Blockonomi+1 Key Takeaways Rivian Stock Price Today: Cooling After a
17 November 2025
·
Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) stock edges higher on November 17, 2025 as Elon Musk accelerates a shift away from China-made parts, Peter Thiel slashes his stake, AI5 chip timelines slip, and analysts clash over robotaxi upside vs. “tough reality.” TSLA stock today: rebound after a choppy stretch As of mid‑afternoon on November 17, 2025, Tesla shares trade near $414.46, up about 2.5% on the day, with intraday moves between roughly $397 and $415. Volume is elevated relative to normal sessions. This bounce comes after a sharp pullback from recent 52‑week highs above $480, driven by: At today’s price, multiple independent analyses still
17 November 2025
·
Ford Stock Soars in 2025 as Wall Street Backs EV Reset, Hybrids and an Amazon-Powered Digital Pivot

Ford Stock Soars in 2025 as Wall Street Backs EV Reset, Hybrids and an Amazon-Powered Digital Pivot

Ford Motor Company (NYSE: F) has quietly become one of 2025’s unlikeliest comeback stories. After years of a sluggish share price, the stock is up roughly one‑third this year, outpacing the broader market, even as its electric‑vehicle unit bleeds billions of dollars. Fresh reports and analyst notes published today, 17 November 2025, show why Wall Street is suddenly “in love” with Ford again — and why the story is more complicated than a simple turnaround. 24/7 Wall St.+1 Key Takeaways A 2025 Rally That Leaves the S&P 500 Behind Ford’s stock has staged a powerful comeback this year. According to
17 November 2025
··
Metsera (MTSR) Delists as Pfizer Closes Up to $10 Billion Obesity Drug Deal – All the Key Updates on November 17, 2025

Metsera (MTSR) Delists as Pfizer Closes Up to $10 Billion Obesity Drug Deal – All the Key Updates on November 17, 2025

Pfizer’s acquisition of Metsera, Inc. (formerly NASDAQ: MTSR) is now effectively complete, Metsera’s stock has been delisted, major index providers are removing the name, and antitrust scholars are using the failed Novo Nordisk bid as a case study in “attempted monopolization.” Here’s a full rundown of what matters today, 17 November 2025, for anyone following Metsera, MTSR, or the obesity‑drug arms race. 1. Where the Metsera–Pfizer Deal Stands Today Pfizer formally closed its acquisition of Metsera on November 13, 2025, after Metsera shareholders approved a sweetened offer that values the obesity biotech at up to $10 billion.Reuters+1 Key terms of
17 November 2025
·
Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor Technologies (NASDAQ: OPEN) is back in the spotlight as a controversial warrant dividend aimed at short sellers dominates headlines, even as Morgan Stanley reiterates a Hold rating and quants flag huge hedge fund flows. Here’s everything investors need to know about OPEN on November 17, 2025. Market snapshot: OPEN stock today As of this afternoon on November 17, 2025, Opendoor Technologies Inc. (NASDAQ: OPEN) is trading around $8.03, down roughly 1% on the day after an explosive run that recently sent the stock above $10. Despite today’s mild pullback, OPEN remains: At the center of today’s news cycle: Opendoor’s
17 November 2025
Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings Inc. (NASDAQ: ONDS), a provider of autonomous drone systems and private wireless networks, packed several major announcements into Monday, November 17, 2025 – including a new multimillion‑dollar European airport contract, the closing of a $225 million acquisition, and fresh bullish analyst signals. Stock Titan Together, the developments underscore how aggressively Ondas is positioning itself at the center of the global counter‑drone and autonomous defense market. Key takeaways for November 17, 2025 As of the latest intraday data on November 17, 2025, ONDS was trading around $7.00 per share, down roughly 2.5% on the day after a sharp run‑up
17 November 2025
··
Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder, Inc. (ASX: LNW, formerly NASDAQ: LNW) has hit a turning point this week. As of 17 November 2025, the cross‑platform gaming group has fully completed its move to a sole listing on the Australian Securities Exchange (ASX), shifted its US$1.5 billion share buyback onto the Australian market, and attracted fresh attention from both institutional investors and brokers. AGB Today’s key Light & Wonder headlines (17 November 2025) ASX‑only listing now in effect Light & Wonder has spent months preparing to exit Nasdaq and concentrate trading on the ASX. The company first notified Nasdaq of its intention to
17 November 2025
·
Beyond Meat (BYND) Stock News Today, November 17, 2025: Class Action Probe, Meme-Stock Hangover and Heavy Dilution Risks

Beyond Meat (BYND) Stock News Today, November 17, 2025: Class Action Probe, Meme-Stock Hangover and Heavy Dilution Risks

Beyond Meat, Inc. (NASDAQ: BYND) is back in the spotlight today as fresh legal scrutiny, shifting short interest, and lingering questions about its debt restructuring collide with a battered share price hovering just above the $1 mark. As of today, Beyond Meat stock is trading around $1.08, giving the plant-based meat maker a market cap of roughly $490 million, a dramatic comedown from its 2019 IPO glory days. Google+2 1. New Securities-Fraud Investigation Announced This Morning The headline news for November 17, 2025 is a fresh securities-fraud class action investigation into Beyond Meat by law firm Bleichmar Fonti & Auld
17 November 2025
Tonix Pharmaceuticals (TNXP) Jumps as TONMYA, First New Fibromyalgia Drug in 15 Years, Hits U.S. Pharmacies – November 17, 2025

Tonix Pharmaceuticals (TNXP) Jumps as TONMYA, First New Fibromyalgia Drug in 15 Years, Hits U.S. Pharmacies – November 17, 2025

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) moved sharply higher today after the company confirmed that TONMYA™ (cyclobenzaprine HCl sublingual tablets), its newly approved fibromyalgia treatment, is now commercially available by prescription across the United States.GlobeNewswire+1 TONMYA Officially Launches in the U.S. Tonix announced at 7:00 a.m. EST that TONMYA is available for pharmacy ordering nationwide and can now be prescribed for adults with fibromyalgia.GlobeNewswire The drug is: TONMYA became the first new FDA‑approved therapy for fibromyalgia in more than 15 years when regulators cleared it on August 15, 2025, based on two pivotal Phase 3 trials involving nearly 1,000 patients.Tonix
17 November 2025
·
Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025

Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025

As of this afternoon, Galmed Pharmaceuticals shares were changing hands around $1.18, up roughly 13% on the day, with more than 41 million shares traded—massively above the stock’s usual daily volume. TipRanks What Galmed Announced Today From its headquarters in Ramat Gan, Israel, Galmed Pharmaceuticals Ltd. announced fresh results from its ongoing collaboration with Virginia Commonwealth University (VCU) on overcoming drug resistance in GI cancers. Galmed Pharmaceuticals+1 The headline: A three‑drug combination of Aramchol + Stivarga + metformin produced a synergistic anti‑tumor effect, significantly enhancing GI tumor cell killing both in vitro and in vivo. According to today’s press release
17 November 2025
···
Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

All of today’s Autonomix (AMIX) news in one glance – 17 November 2025 As of this afternoon on November 17, 2025, all company‑specific news about Autonomix Medical, Inc. (NASDAQ: AMIX) centers on the same core development: new quality‑of‑life data from its pancreatic cancer PoC 1 study and the stock’s reaction to it. The main headlines are: No additional Autonomix‑specific earnings reports, SEC filings or separate product announcements have been released today beyond coverage of this PoC 1 subgroup analysis and its market impact, based on public news and filings available at the time of writing. Last10K+1 What Autonomix announced today
17 November 2025
·
Michael Saylor’s Strategy Bets $835M on the Bitcoin Dip as Crypto Market Slides Below $95K

Michael Saylor’s Strategy Bets $835M on the Bitcoin Dip as Crypto Market Slides Below $95K

Bitcoin may be stuck in its deepest correction of 2025, but Michael Saylor is leaning in, not backing out. Over the past week, Strategy Inc. (MSTR) — the enterprise software company turned Bitcoin mega‑holder led by executive chairman Michael Saylor — acquired 8,178 BTC for about $835.6 million, its largest weekly buy since July.Bloomberg+1 At the same time, Saylor has a clear message for nervous investors watching Bitcoin bleed: HODL. Key facts at a glance Strategy’s Biggest Bitcoin Buy Since July According to a Monday filing with the U.S. Securities and Exchange Commission, Strategy disclosed that it had bought $835.6
17 November 2025
·
1 … 1,296 1,297 1,298 1,299 1,300 … 1,633

Stock Market Today

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

7 February 2026
The Philadelphia Semiconductor Index jumped 5.7% to 8,048.6 on Friday, with Nvidia up 7.87% and AMD rising 8.28%. The surge followed new forecasts showing global chip sales could hit $1 trillion in 2026. Amazon expects a 50% increase in capital spending this year, fueling demand for chips. The Dow Jones crossed 50,000, helped by gains in chipmakers.
Oil stocks jump on Iran risk lift for crude — what to watch before Monday

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

7 February 2026
U.S. oil stocks surged Friday as crude prices rose on renewed Middle East tensions. Exxon Mobil gained 2.0%, ConocoPhillips 2.5%, and Occidental Petroleum 2.7%. Refiners rallied after a national union deal eased strike risk, though BP’s Whiting plant faces a local dispute. Brent settled at $68.05 a barrel, up 0.74%.
Silver price rebound masks fresh stress after CME lifts margins again

Silver price rebound masks fresh stress after CME lifts margins again

7 February 2026
Spot silver surged 8.6% to $77.33 an ounce Friday after dropping below $65, but still lost over 8.7% for the week. CME Group raised margin requirements for COMEX silver futures to 18% from 15%, effective after Feb. 6. China’s UBS SDIC Silver Futures Fund hit its 10% down limit for a fifth session. Traders await key U.S. jobs and inflation data next week.
Go toTop